­
­
­
­

Inventi Impact: Pharm Analysis & Quality Assurance

Articles

  • Inventi:ppaqa/24806/18
    Development and Validation of a Stability-Indicating HPLC Method for the Simultaneous\nDetermination of Florfenicol and Flunixin Meglumine Combination in an Injectable Solution
    01-Jan-1970 Research 2018 : January - March
    Nidal Batrawi, Hani Naseef, Fuad Al-Rimawi

    Thecombination of the powerful antimicrobial agent florfenicol and the nonsteroidal anti-inflammatory flunixin meglumine is used\nfor the treatment of bovine respiratory disease (BRD) and control of BRD-associated pyrexia, in beef and nonlactating dairy cattle.\nThis study describes the development and validation of an HPLC-UV method for the simultaneous determination of florfenicol and\nflunixin, in an injectable preparation with a mixture of excipients. The proposed RP-HPLC method was developed by a reversed\nphase- (RP-) C18e (250mmÃ?â?? 4.6 mm, 5

    How to Cite this Article
    CC Compliant Citation: Nidal Batrawi, Hani Naseef, and Fuad Al-Rimawi, â??Development and Validation of a Stability-Indicating HPLC\nMethod for the Simultaneous Determination of Florfenicol and Flunixin Meglumine Combination in an Injectable Solution,â? Journal of\nAnalytical Methods in Chemistry, vol. 2017, Article ID 1529280, 7 pages, 2017. doi:10.1155/2017/1529280, https://\ncreativecommons.org/licenses/by/4.0/.
    Download Full Text